First Turn Management »

Biohaven shares owned by First Turn Management

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by First Turn Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $20M 477k 42.80

More positions owned by First Turn Management

Cytokinetics Com New (CYTK)
Cymabay Therapeutics
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Krystal Biotech (KRYS)
Legend Biotech Corp Sponsored Ads (LEGN)
Karuna Therapeutics Ord
Transmedics Group (TMDX)
Insulet Corporation (PODD)
Day One Biopharmaceuticals I (DAWN)
Mirum Pharmaceuticals (MIRM)
Verona Pharma Sponsored Ads (VRNA)
Dex (DXCM)
Axsome Therapeutics (AXSM)

View all positions for First Turn Management

Top funds holding Biohaven

Stifel Financial
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Perceptive Advisors
Vanguard Group
Redmile Group
Holocene Advisors
Citadel Advisors
Avidity Partners Management
Bellevue Group
Goldman Sachs Group
Oracle Investment Management
Charles Schwab Investment Management
First Turn Management

View all funds holding Biohaven